TVRD
Tvardi Therapeutics
TVRD
TVRD
133 hedge funds and large institutions have $426M invested in Tvardi Therapeutics in 2020 Q1 according to their latest regulatory filings, with 18 funds opening new positions, 37 increasing their positions, 43 reducing their positions, and 32 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more ownership
Funds ownership: →
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
14% less repeat investments, than reductions
Existing positions increased: 37 | Existing positions reduced: 43
16% less capital invested
Capital invested by funds: $505M → $426M (-$79.1M)
44% less first-time investments, than exits
New positions opened: 18 | Existing positions closed: 32
Holders
133
Holding in Top 10
2
Calls
$6.31M
Puts
$4.4M
Top Buyers
| 1 | +$11.6M | |
| 2 | +$7.83M | |
| 3 | +$7.29M | |
| 4 |
Bank of America
Charlotte,
North Carolina
|
+$6.38M |
| 5 |
D.E. Shaw & Co
New York
|
+$3.26M |
Top Sellers
| 1 | -$10.5M | |
| 2 | -$4.95M | |
| 3 | -$1.45M | |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
-$1.34M |
| 5 |
Arrowstreet Capital
Boston,
Massachusetts
|
-$1.16M |